MAPK3 and non-small cell lung carcinoma: The response to BAY-293 in BH1362 NSCLC KRAS G12C cells was similar to the alterations found in Aspc1 cells, namely concerning CREB, EGFR and ERK1/2 with additional changes in beta-catenin and Src kinases.